About a third of patients with relapsed or refractory classic Hodgkin lymphoma (r/r CHL) succumb…
karnottJanuary 31, 2024
Microbion Corporation announced that the company has been granted a second orphan drug designation for…
karnottJanuary 30, 2024
The Michael Smith Laboratories is pleased to highlight one of our outstanding graduate students, Heather…
karnottJanuary 29, 2024
The College and Community Innovation (CCI) program’s Mobilize grants 2024 competition, managed by the Natural…
karnottJanuary 29, 2024
Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, presented positive Phase 2 safety and…
karnottJanuary 26, 2024
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a…
karnottJanuary 26, 2024
Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy.…
karnottJanuary 25, 2024
Endometriosis affects nearly 1 in 10 women in Canada and an unmeasured number of gender…
karnottJanuary 25, 2024
Six UBC faculty of medicine community members have been honoured by the Canadian Association for…
karnottJanuary 25, 2024
